Abstract:Class 1 integrons accumulate antibiotic resistance genes by site-specific recombination at aatI-1 sites. Captured genes are transcribed from a promoter located within the integron; for class 1 integrons, the first gene to be transcribed and translated normally encodes an aminoglycoside antibiotic resistance protein (either an acetyltransferase [AAC] or adenyltransferase [AAD]). The leader RNA from the Pseudomonas fluorescens class 1 integron contains an aminoglycoside-sensing riboswitch RNA that controls the expression of the downstream aminoglycoside resistance gene. Here, we explore the relationship between integron-dependent DNA recombination and potential aminoglycoside-sensing riboswitch products of recombination derived from a series of aminoglycoside-resistant clinical strains. Sequence analysis of the clinical strains identified a series of sequence variants that were associated with class I integron-derived aminoglycoside-resistant (both aac and aad) recombinants. For the aac recombinants, representative sequences showed up to 6-fold aminoglycoside-dependent regulation of reporter gene expression. Microscale thermophoresis (MST) confirmed RNA binding. Covariance analysis generated a secondary-structure model for the RNA that is an independent verification of previous models that were derived from mutagenesis and chemical probing data and that was similar to that of the P. fluorescens riboswitch RNA. The aminoglycosides were among the first antibiotics to be used clinically, and the data suggest that in an aminoglycoside-rich environment, functional riboswitch recombinants were selected during integron-mediated recombination to regulate aminoglycoside resistance. The incorporation of a functional aminoglycoside-sensing riboswitch by integron recombination confers a selective advantage for the expression of resistance genes of diverse origins.

Riboswitch Control of Aminoglycoside Antibiotic Resistance

Riboswitch Control Of Induction Of Aminoglycoside Resistance Acetyl And Adenyl-Transferases

An aminoglycoside sensing riboswitch controls the expression of aminoglycoside resistance acetyltransferase and adenyltransferases.

Aminoglycoside Riboswitch Control of the Expression of Integron Associated Aminoglycoside Resistance Adenyltransferases

Integron-Derived Aminoglycoside-Sensing Riboswitches Control Aminoglycoside Acetyltransferase Resistance Gene Expression

Recent Advances in Rna Riboswitch

Riboswitch Mechanisms for Regulation of P1 Helix Stability

Structural insights into amino acid binding and gene control by a lysine riboswitch

A sensitive and scalable fluorescence anisotropy single stranded RNA targeting approach for monitoring riboswitch conformational states

The current riboswitch landscape in Clostridioides difficile

Opportunities for Riboswitch Inhibition by Targeting Co-Transcriptional RNA Folding Events

Insights into the Regulatory Landscape of the Lysine Riboswitch

Mechanistic analysis of Riboswitch Ligand interactions provides insights into pharmacological control over gene expression

Effect of Mutations on Binding of Ligands to Guanine Riboswitch Probed by Free Energy Perturbation and Molecular Dynamics Simulations

Flipping the script: Understanding riboswitches from an alternative perspective

A SAM-I riboswitch with the ability to sense and respond to uncharged initiator tRNA

A nascent riboswitch helix orchestrates robust transcriptional regulation through signal integration

The Escherichia coli ribB riboswitch senses flavin mononucleotide within a defined transcriptional window

uORF‐mediated riboregulation controls transcription of whiB7/wblC antibiotic resistance gene

Direct and indirect control of Rho-dependent transcription termination by the Escherichia coli lysC riboswitch